Importo totale (1 articolo articoli):
Destinazione ordine:
light donald w (67 risultati)
Vai alla pagina principale dei risultati di ricerca
Filtri di ricerca
Tipo di articolo
- Tutti i tipi di prodotto
- Libri (67)
- Riviste e Giornali (Nessun altro risultato corrispondente a questo perfezionamento)
- Fumetti (Nessun altro risultato corrispondente a questo perfezionamento)
- Spartiti (Nessun altro risultato corrispondente a questo perfezionamento)
- Arte, Stampe e Poster (Nessun altro risultato corrispondente a questo perfezionamento)
- Fotografie (Nessun altro risultato corrispondente a questo perfezionamento)
- Mappe (Nessun altro risultato corrispondente a questo perfezionamento)
- Manoscritti e Collezionismo cartaceo (Nessun altro risultato corrispondente a questo perfezionamento)
Condizioni Maggiori informazioni
Legatura
Ulteriori caratteristiche
- Prima ed. (3)
- Copia autograf. (Nessun altro risultato corrispondente a questo perfezionamento)
- Sovracoperta (3)
- Con foto (21)
- Non Print on Demand (55)
Lingua (2)
Spedizione gratuita
Paese del venditore
Valutazione venditore
-
The Risks of Prescription Drugs (A Columbia / SSRC Book (Privatization of Risk))
Libro 6 di 6: A Columbia/SSRC Book (Privatization of Risk)Lingua: Inglese
Editore: Columbia University Press (edition Illustrated), 2010
ISBN 10: 0231146930 ISBN 13: 9780231146937
Da: BooksRun, Philadelphia, PA, U.S.A.
Valutazione del venditore 5 su 5 stelle
Paperback. Condizione: Very Good. Illustrated. It's a well-cared-for item that has seen limited use. The item may show minor signs of wear. All the text is legible, with all pages included. It may have slight markings and/or highlighting.
-
The Risks of Prescription Drugs
Libro 6 di 6: A Columbia/SSRC Book (Privatization of Risk)Da: ThriftBooks-Dallas, Dallas, TX, U.S.A.
Valutazione del venditore 5 su 5 stelle
Paperback. Condizione: Good. No Jacket. Pages can have notes/highlighting. Spine may show signs of wear. ~ ThriftBooks: Read More, Spend Less.
-
Condizione: acceptable. Used - Acceptable: All pages and the cover are intact, but shrink wrap, dust covers, or boxed set case may be missing. Pages may include limited notes, highlighting, or minor water damage but the text is readable. Item may be missing bundled media.
-
Benchmarks of Fairness for Health Care Reform
Lingua: Inglese
Editore: Oxford University Press, Incorporated, 1996
ISBN 10: 0195102371 ISBN 13: 9780195102376
Da: Better World Books, Mishawaka, IN, U.S.A.
Valutazione del venditore 5 su 5 stelle
Prima edizione
Condizione: Good. 1st Edition. Former library copy. Pages intact with minimal writing/highlighting. The binding may be loose and creased. Dust jackets/supplements are not included. Includes library markings. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.
-
Risks of Prescription Drugs
Libro 6 di 6: A Columbia/SSRC Book (Privatization of Risk)Da: GreatBookPrices, Columbia, MD, U.S.A.
Valutazione del venditore 5 su 5 stelle
Condizione: As New. Unread book in perfect condition.
-
The Risks of Prescription Drugs
Libro 6 di 6: A Columbia/SSRC Book (Privatization of Risk)Da: PBShop.store UK, Fairford, GLOS, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 22,09
Spedizione EUR 4,82
Spedito da Regno Unito a U.S.A.Quantità: 2 disponibili
Aggiungi al carrelloPAP. Condizione: New. New Book. Shipped from UK. Established seller since 2000.
-
The Risks of Prescription Drugs
Libro 6 di 6: A Columbia/SSRC Book (Privatization of Risk)Lingua: Inglese
Editore: Columbia University Press, US, 2010
ISBN 10: 0231146930 ISBN 13: 9780231146937
Paperback. Condizione: New. Few people realize that prescription drugs have become a leading cause of death, disease, and disability. Adverse reactions to widely used drugs, such as psychotropics and birth control pills, as well as biologicals, result in FDA warnings against adverse reactions. The Risks of Prescription Drugs describes how most drugs approved by the FDA are under-tested for adverse drug reactions, yet offer few new benefits. Drugs cause more than 2.2 million hospitalizations and 110,000 hospital-based deaths a year. Serious drug reactions at home or in nursing homes would significantly raise the total. Women, older people, and people with disabilities are least used in clinical trials and most affected. Health policy experts Donald Light, Howard Brody, Peter Conrad, Allan Horwitz, and Cheryl Stults describe how current regulations reward drug companies to expand clinical risks and create new diseases so millions of patients are exposed to unnecessary risks, especially women and the elderly. They reward developing marginally better drugs rather than discovering breakthrough, life-saving drugs.The Risks of Prescription Drugs tackles critical questions about the pharmaceutical industry and the privatization of risk. To what extent does the FDA protect the public from serious side effects and disasters? What is the effect of giving the private sector and markets a greater role and reducing public oversight? This volume considers whether current rules and incentives put patients' health at greater risk, the effect of the expansion of disease categories, the industry's justification of high U.S. prices, and the underlying shifts in the burden of risk borne by individuals in the world of pharmaceuticals. Chapters cover risks of statins for high cholesterol, SSRI drugs for depression and anxiety, and hormone replacement therapy for menopause. A final chapter outlines six changes to make drugs safer and more effective. Suitable for courses on health and aging, gender, disability, and minority studies, this book identifies the Risk Proliferation Syndrome that maximizes the number of people exposed to these risks. Additional Columbia / SSRC books on the privatization of risk and its implications for Americans: Bailouts: Public Money, Private ProfitEdited by Robert E.Wright Disaster and the Politics of InterventionEdited by Andrew Lakoff Health at Risk: America's Ailing Health System-and How to Heal ItEdited by Jacob S. Hacker Laid Off, Laid Low: Political and Economic Consequences of Employment InsecurityEdited by Katherine S. Newman Pensions, Social Security, and the Privatization of RiskEdited by Mitchell A. Orenstein.
-
Risks of Prescription Drugs
Libro 6 di 6: A Columbia/SSRC Book (Privatization of Risk)Da: GreatBookPrices, Columbia, MD, U.S.A.
Valutazione del venditore 5 su 5 stelle
Condizione: New.
-
The Risks of Prescription Drugs
Libro 6 di 6: A Columbia/SSRC Book (Privatization of Risk)Da: PBShop.store US, Wood Dale, IL, U.S.A.
Valutazione del venditore 5 su 5 stelle
PAP. Condizione: New. New Book. Shipped from UK. Established seller since 2000.
-
The Risks of Prescription Drugs (A Columbia / SSRC Book (Privatization of Risk))
Libro 6 di 6: A Columbia/SSRC Book (Privatization of Risk)Da: Midtown Scholar Bookstore, Harrisburg, PA, U.S.A.
Valutazione del venditore 5 su 5 stelle
Hardcover. Condizione: Good. no dj, some wear, still nice! - may have remainder mark or previous owner's name Standard-sized.
-
The Risks of Prescription Drugs
Libro 6 di 6: A Columbia/SSRC Book (Privatization of Risk)Da: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
Valutazione del venditore 5 su 5 stelle
EUR 21,84
Spedizione EUR 10,50
Spedito da Irlanda a U.S.A.Quantità: 1 disponibili
Aggiungi al carrelloCondizione: New. Editor(s): Light, Don. Series: Columbia / SSRC Book (Privatization of Risk). Num Pages: 184 pages, figures. BIC Classification: MMG. Category: (P) Professional & Vocational. Dimension: 208 x 142 x 11. Weight in Grams: 254. Series: Columbia / SSRC Book (Privatization of Risk). 184 pages, illustrations. Editor(s): Light, Don. Cateogry: (P) Professional & Vocational. BIC Classification: MMG. Dimension: 208 x 142 x 11. Weight: 254. . 2010. Paperback. . . . .
-
EUR 17,89
Spedizione EUR 15,76
Spedito da Regno Unito a U.S.A.Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Good. This is an ex-library book and may have the usual library/used-book markings inside.This book has soft covers. In good all round condition. Please note the Image in this listing is a stock photo and may not match the covers of the actual item,350grams, ISBN:9780231146937.
-
The Risks of Prescription Drugs
Libro 6 di 6: A Columbia/SSRC Book (Privatization of Risk)Da: Revaluation Books, Exeter, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 22,92
Spedizione EUR 11,59
Spedito da Regno Unito a U.S.A.Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. 167 pages. 8.25x5.50x0.50 inches. In Stock.
-
The Risks of Prescription Drugs
Libro 6 di 6: A Columbia/SSRC Book (Privatization of Risk)Da: Kennys Bookstore, Olney, MD, U.S.A.
Valutazione del venditore 5 su 5 stelle
Condizione: New. Editor(s): Light, Don. Series: Columbia / SSRC Book (Privatization of Risk). Num Pages: 184 pages, figures. BIC Classification: MMG. Category: (P) Professional & Vocational. Dimension: 208 x 142 x 11. Weight in Grams: 254. Series: Columbia / SSRC Book (Privatization of Risk). 184 pages, illustrations. Editor(s): Light, Don. Cateogry: (P) Professional & Vocational. BIC Classification: MMG. Dimension: 208 x 142 x 11. Weight: 254. . 2010. Paperback. . . . . Books ship from the US and Ireland.
-
The Risks of Prescription Drugs
Libro 6 di 6: A Columbia/SSRC Book (Privatization of Risk)Da: THE SAINT BOOKSTORE, Southport, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 22,07
Spedizione EUR 15,78
Spedito da Regno Unito a U.S.A.Quantità: 2 disponibili
Aggiungi al carrelloPaperback / softback. Condizione: New. New copy - Usually dispatched within 4 working days.
-
The Risks of Prescription Drugs (Columbia / SSRC Book (Privatization of Risk)) (A Columbia / SSRC Book (Privatization of Risk))
Libro 6 di 6: A Columbia/SSRC Book (Privatization of Risk)Lingua: Inglese
Editore: Columbia University Press 2008-09-01, 2008
ISBN 10: 0231146930 ISBN 13: 9780231146937
Da: Chiron Media, Wallingford, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 19,93
Spedizione EUR 17,95
Spedito da Regno Unito a U.S.A.Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: New.
-
Hardcover. Condizione: Very Good. Condizione sovraccoperta: Very Good. Panels lightly soiled. Small tear on base of spine. Spine discolored. Name of previous owner in ink on FFEP. Otherwise this copy is clean and unmarked in very good condition. 605 pages.
-
Risks of Prescription Drugs
Libro 6 di 6: A Columbia/SSRC Book (Privatization of Risk)Da: GreatBookPricesUK, Woodford Green, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 22,05
Spedizione EUR 17,38
Spedito da Regno Unito a U.S.A.Quantità: 1 disponibili
Aggiungi al carrelloCondizione: New.
-
Risks of Prescription Drugs
Libro 6 di 6: A Columbia/SSRC Book (Privatization of Risk)Da: GreatBookPricesUK, Woodford Green, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 22,59
Spedizione EUR 17,38
Spedito da Regno Unito a U.S.A.Quantità: 1 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
-
Good Pharma: The Public-Health Model of the Mario Negri Institute
Da: Books for Life, LAUREL, MD, U.S.A.
Valutazione del venditore 5 su 5 stelle
Condizione: very_good. Book is in very good condition. Clean with little to no signs of wear or markings highlights.
-
Benchmarks of Fairness for Health Care Reform
Da: GreatBookPrices, Columbia, MD, U.S.A.
Valutazione del venditore 5 su 5 stelle
EUR 54,10
Spedizione EUR 2,28
Spedito in U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
-
Good Pharma : The Public-Health Model of the Mario Negri Institute
Da: GreatBookPrices, Columbia, MD, U.S.A.
Valutazione del venditore 5 su 5 stelle
EUR 55,77
Spedizione EUR 2,28
Spedito in U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
-
Good Pharma: The Public-Health Model of the Mario Negri Institute (Hardback or Cased Book)
Lingua: Inglese
Editore: Palgrave MacMillan 7/1/2015, 2015
ISBN 10: 1137388331 ISBN 13: 9781137388339
Da: BargainBookStores, Grand Rapids, MI, U.S.A.
Valutazione del venditore 5 su 5 stelle
Hardback or Cased Book. Condizione: New. Good Pharma: The Public-Health Model of the Mario Negri Institute. Book.
-
Benchmarks of Fairness for Health Care Reform
Da: GreatBookPrices, Columbia, MD, U.S.A.
Valutazione del venditore 5 su 5 stelle
EUR 60,59
Spedizione EUR 2,28
Spedito in U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
-
Good Pharma : The Public-Health Model of the Mario Negri Institute
Da: GreatBookPrices, Columbia, MD, U.S.A.
Valutazione del venditore 5 su 5 stelle
EUR 64,39
Spedizione EUR 2,28
Spedito in U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
-
Condizione: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
-
Good Pharma
Da: Rarewaves.com USA, London, LONDO, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 67,77
Spedizione gratuita
Spedito da Regno Unito a U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloHardback. Condizione: New.
-
EUR 6,99
Spedizione EUR 62,30
Spedito da Germania a U.S.A.Quantità: 1 disponibili
Aggiungi al carrellohardcover. Condizione: Befriedigend. Seiten; 9780262121095.4 Gewicht in Gramm: 2.
-
The Risks of Prescription Drugs
Libro 6 di 6: A Columbia/SSRC Book (Privatization of Risk)Lingua: Inglese
Editore: Columbia University Press, US, 2010
ISBN 10: 0231146930 ISBN 13: 9780231146937
Da: Rarewaves USA United, OSWEGO, IL, U.S.A.
Valutazione del venditore 5 su 5 stelle
Paperback. Condizione: New. Few people realize that prescription drugs have become a leading cause of death, disease, and disability. Adverse reactions to widely used drugs, such as psychotropics and birth control pills, as well as biologicals, result in FDA warnings against adverse reactions. The Risks of Prescription Drugs describes how most drugs approved by the FDA are under-tested for adverse drug reactions, yet offer few new benefits. Drugs cause more than 2.2 million hospitalizations and 110,000 hospital-based deaths a year. Serious drug reactions at home or in nursing homes would significantly raise the total. Women, older people, and people with disabilities are least used in clinical trials and most affected. Health policy experts Donald Light, Howard Brody, Peter Conrad, Allan Horwitz, and Cheryl Stults describe how current regulations reward drug companies to expand clinical risks and create new diseases so millions of patients are exposed to unnecessary risks, especially women and the elderly. They reward developing marginally better drugs rather than discovering breakthrough, life-saving drugs.The Risks of Prescription Drugs tackles critical questions about the pharmaceutical industry and the privatization of risk. To what extent does the FDA protect the public from serious side effects and disasters? What is the effect of giving the private sector and markets a greater role and reducing public oversight? This volume considers whether current rules and incentives put patients' health at greater risk, the effect of the expansion of disease categories, the industry's justification of high U.S. prices, and the underlying shifts in the burden of risk borne by individuals in the world of pharmaceuticals. Chapters cover risks of statins for high cholesterol, SSRI drugs for depression and anxiety, and hormone replacement therapy for menopause. A final chapter outlines six changes to make drugs safer and more effective. Suitable for courses on health and aging, gender, disability, and minority studies, this book identifies the Risk Proliferation Syndrome that maximizes the number of people exposed to these risks. Additional Columbia / SSRC books on the privatization of risk and its implications for Americans: Bailouts: Public Money, Private ProfitEdited by Robert E.Wright Disaster and the Politics of InterventionEdited by Andrew Lakoff Health at Risk: America's Ailing Health System-and How to Heal ItEdited by Jacob S. Hacker Laid Off, Laid Low: Political and Economic Consequences of Employment InsecurityEdited by Katherine S. Newman Pensions, Social Security, and the Privatization of RiskEdited by Mitchell A. Orenstein.
-
Good Pharma: The Public-Health Model of the Mario Negri Institute
Da: Ria Christie Collections, Uxbridge, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 60,63
Spedizione EUR 13,88
Spedito da Regno Unito a U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
